Organization
Amsterdam Rheumatology and Immunology Center | Reade, Amsterdam, Netherlands
6 abstracts
Abstract
ASSOCIATION BETWEEN PLASMA LIPIDS, DISEASE ACTIVITY AND PCSK9 LEVELS IN RA PATIENTS Org: Amsterdam Rheumatology and Immunology Center | Reade, Amsterdam, Netherlands, University of la Reúnion, Saint-Denis, University of Nantes, Nantes, France, Academic Medical Center Amsterdam & Atrium Medical Center, Heerlen, Netherlands, Amsterdam Rheumatology and Immunology Center | VU University Medical Center, Amsterdam, Netherlands,
Abstract
ANTIDRUG ANTIBODIES DETECTION IS STRONGLY INFLUENCED BY THE TYPE OF ASSAY USED Org: Amsterdam Rheumatology and Immunology Center | Reade, Amsterdam, Netherlands, Amsterdam Rheumatology and Immunology Center | VU Medical Center, Amsterdam, Netherlands, Department of Immunopathology, Sanquin Research and Landsteiner Laboratory Academic Medical Center, Amsterdam, Netherlands,
Abstract
ACHIEVING THE TREATMENT TARGETS OF REMISSION OR LOW DISEASE ACTIVITY (LDA) IN PSORIATIC ARTHRITIS (PSA) IS ASSOCIATED WITH SIGNIFICANTLY IMPROVED QUALITY OF LIFE, FUNCTION AND PAINOrg: Janssen-Cilag B.V, Tilburg, Netherlands, University Hospitals Leuven, Leuven, Belgium, Fondazione Policlinico Gemelli-IRCCS-Università Cattolica del Sacro Cuore, Rome, Italy, Nasonova Research Institute of Rheumatology, Moscow, Russian Federation, Janssen-Cilag B.V, Brussels, Belgium,
Abstract
ANTI-TNF TREATMENT IN RHEUMATOID ARTHRITIS AND ANKYLOSING SPONDYLITIS PATIENTS IS ASSOCIATED WITH A STRONG INCREASE OF PALMOPLANTAR PUSTULOSIS BUT NOT OF PSORIASIS VULGARIS Org: Amsterdam Rheumatology and Immunology Center | Reade, Amsterdam, Netherlands, Department of Immunopathology, Sanquin Research and Landsteiner Laboratory Academic Medical Centre, Amsterdam, Netherlands,
Abstract
BELIMUMAB INCREASES SRI-4 RESPONSE RATES VERSUS PLACEBO IN EARLY ACTIVE SYSTEMIC LUPUS ERYTHEMATOSUS: A LARGE INTEGRATED ANALYSIS OF BELIMUMAB TRIALSOrg: GSK Research and Development Upper Providence, Collegeville, PA, Brigham and Women’s Hospital, Oklahoma Medical Research Foundation, Arthritis & Clinical Immunology, Oklahoma City, United States of America, Rheumatology unit, Department of Medicine, Karolinska Institute, Stockholm, Sweden, Hokkaido University Hospital Cancer Center,
Abstract
BELIMUMAB REDUCES DISEASE FLARES VERSUS PLACEBO IN ADULTS WITH EARLY ACTIVE SYSTEMIC LUPUS ERYTHEMATOSUS: RESULTS OF A LARGE INTEGRATED ANALYSISOrg: GSK Research and Development Upper Providence, Collegeville, PA, Oklahoma Medical Research Foundation, Arthritis & Clinical Immunology, Oklahoma City, United States of America, Brigham and Women’s Hospital, Hokkaido University Hospital Cancer Center, Amsterdam Rheumatology and Immunology Center | Reade, Amsterdam, Netherlands,